OII 241018 25.00C (OII241018C25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

OII241018C25000

Watchlist

0.05
-0.05-50.00%

15min DelayClose Oct 18 15:49 ET

0.05High0.05Low

Intraday

5D
Daily

News

What's in Store for Oceaneering International Stock in Q3 Earnings?
Zacks Oct 18 08:00 ET
Earnings Preview: OII to Report Financial Results Post-market on October 23
Moomoo NewsOct 17 21:00 ET
Oceaneering International (OII) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Yahoo FinanceOct 16 10:01 ET
If EPS Growth Is Important To You, Oceaneering International (NYSE:OII) Presents An Opportunity
Simply Wall StOct 7 06:54 ET
Oceaneering Announces Dates for Third Quarter 2024 Earnings Release and Conference Call
BusinesswireSep 25 13:00 ET
Is Oceaneering International (NYSE:OII) A Risky Investment?
Simply Wall StSep 23 12:57 ET

Comments

Moomoo AI

Feb 29 07:55

The modest level of insider ownership and lack of insider transactions in the last three months suggest alignment with shareholder interests. However, significant insider selling over the past year could be a red flag for investors.

Insiders At Oceaneering International Sold US$2.5m In Stock, Alluding To Potential Weakness

Moomoo AI

Jan 29 05:53

Oceaneering International, Inc.'s transition from loss to profitability justifies its strong share price gain. Despite slowing gains, the company's future financial health remains crucial for shareholders.

Oceaneering International (NYSE:OII) Delivers Shareholders Impressive 37% CAGR Over 3 Years, Surging 6.4% in the Last Week Alone

Moomoo AI

Jan 11 07:09

Oceaneering International's respectable ROE is overshadowed by its high debt level. Investors should consider the company's performance potential in less favorable credit markets. High ROE without debt typically indicates a high-quality business.

Did Oceaneering International, Inc. (NYSE:OII) Use Debt To Deliver Its ROE Of 13%?

Moomoo Breakfast US

Jun 10, 2022 07:20

Columns Today's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more

Gainers:
• $Cogent Biosciences (COGT.US)$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions (UNVR.US)$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts (MTN.US)$ +6% (In reaction to earnings/guidance)
• $BeiGene (BGNE.US)$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...